Author:
Yao Yushi,Zhou Jihao,Wang Lixin,Gao Xiaoning,Ning Qiaoyang,Jiang Mengmeng,Wang Jia,Wang Lili,Yu Li
Publisher
Public Library of Science (PLoS)
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chidamide plus prednisone, cyclophosphamide, and thalidomide for relapsed or refractory peripheral T-cell lymphoma: A multicenter phase II trial;Chinese Medical Journal;2023-10-13
2. A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma;Frontiers in Oncology;2023-08-11
3. Efficacy and safety of an HDACi- and HMA-based protocol in adults with acute myeloid leukemia of intermediate- and adverse-risk categories: a retrospective study;Hematology;2023-06-06
4. Chidamide, a novel histone deacetylase inhibitor, inhibits laryngeal cancer progression in vitro and in vivo;The International Journal of Biochemistry & Cell Biology;2023-05
5. A phase II study of chidamide, cytarabine, aclarubicin, granulocyte colony-stimulating factor, and donor lymphocyte infusion for relapsed acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation;Medical Oncology;2023-01-10